Deletion of 5q by t(5;17) in therapy-related myelodysplastic syndrome
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 48 (1) , 49-52
- https://doi.org/10.1016/0165-4608(90)90215-v
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- der(5)t(5;7)(q11.2;p11.2): A new recurring abnormality in malignant myeloid disordersCancer Genetics and Cytogenetics, 1989
- Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemiasCancer Genetics and Cytogenetics, 1987
- Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.Journal of Clinical Oncology, 1986
- Combined trisomy 1q and monosomy 7q due to translocation 1;7 in myelodysplastic syndromesCancer Genetics and Cytogenetics, 1985
- The 5q− anomalyCancer Genetics and Cytogenetics, 1985
- Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 casesBlood, 1985
- Translocation 1;7 in dyshematopoiesis: Possibly induced with a nonrandom geographic distributionCancer Genetics and Cytogenetics, 1984
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982